Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

256 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Urinary exosomes reveal protein signatures in hypertensive patients with albuminuria.
Gonzalez-Calero L, Martínez PJ, Martin-Lorenzo M, Baldan-Martin M, Ruiz-Hurtado G, de la Cuesta F, Calvo E, Segura J, Lopez JA, Vázquez J, Barderas MG, Ruilope LM, Vivanco F, Alvarez-Llamas G. Gonzalez-Calero L, et al. Among authors: vivanco f. Oncotarget. 2017 Jul 4;8(27):44217-44231. doi: 10.18632/oncotarget.17787. Oncotarget. 2017. PMID: 28562335 Free PMC article.
Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis.
Zubiri I, Posada-Ayala M, Sanz-Maroto A, Calvo E, Martin-Lorenzo M, Gonzalez-Calero L, de la Cuesta F, Lopez JA, Fernandez-Fernandez B, Ortiz A, Vivanco F, Alvarez-Llamas G. Zubiri I, et al. Among authors: vivanco f. J Proteomics. 2014 Jan 16;96:92-102. doi: 10.1016/j.jprot.2013.10.037. Epub 2013 Nov 7. J Proteomics. 2014. PMID: 24211404 Clinical Trial.
Kidney tissue proteomics reveals regucalcin downregulation in response to diabetic nephropathy with reflection in urinary exosomes.
Zubiri I, Posada-Ayala M, Benito-Martin A, Maroto AS, Martin-Lorenzo M, Cannata-Ortiz P, de la Cuesta F, Gonzalez-Calero L, Barderas MG, Fernandez-Fernandez B, Ortiz A, Vivanco F, Alvarez-Llamas G. Zubiri I, et al. Among authors: vivanco f. Transl Res. 2015 Nov;166(5):474-484.e4. doi: 10.1016/j.trsl.2015.05.007. Epub 2015 May 23. Transl Res. 2015. PMID: 26072307
Prediction of development and maintenance of high albuminuria during chronic renin-angiotensin suppression by plasma proteomics.
Baldan-Martin M, de la Cuesta F, Alvarez-Llamas G, Gonzalez-Calero L, Ruiz-Hurtado G, Moreno-Luna R, Mourino-Alvarez L, Sastre-Oliva T, Segura J, Padial LR, Vivanco F, Ruilope LM, Barderas MG. Baldan-Martin M, et al. Among authors: vivanco f. Int J Cardiol. 2015 Oct 1;196:170-7. doi: 10.1016/j.ijcard.2015.05.148. Epub 2015 May 29. Int J Cardiol. 2015. PMID: 26119064
Urinary alpha-1 antitrypsin and CD59 glycoprotein predict albuminuria development in hypertensive patients under chronic renin-angiotensin system suppression.
Gonzalez-Calero L, Martin-Lorenzo M, de la Cuesta F, Maroto AS, Baldan-Martin M, Ruiz-Hurtado G, Pulido-Olmo H, Segura J, Barderas MG, Ruilope LM, Vivanco F, Alvarez-Llamas G. Gonzalez-Calero L, et al. Among authors: vivanco f. Cardiovasc Diabetol. 2016 Jan 16;15:8. doi: 10.1186/s12933-016-0331-7. Cardiovasc Diabetol. 2016. PMID: 26772976 Free PMC article.
Plasma Molecular Signatures in Hypertensive Patients With Renin-Angiotensin System Suppression: New Predictors of Renal Damage and De Novo Albuminuria Indicators.
Baldan-Martin M, Mourino-Alvarez L, Gonzalez-Calero L, Moreno-Luna R, Sastre-Oliva T, Ruiz-Hurtado G, Segura J, Lopez JA, Vazquez J, Vivanco F, Alvarez-Llamas G, Ruilope LM, de la Cuesta F, Barderas MG. Baldan-Martin M, et al. Among authors: vivanco f. Hypertension. 2016 Jul;68(1):157-66. doi: 10.1161/HYPERTENSIONAHA.116.07412. Epub 2016 May 23. Hypertension. 2016. PMID: 27217411
Hypertensive patients exhibit an altered metabolism. A specific metabolite signature in urine is able to predict albuminuria progression.
Gonzalez-Calero L, Martin-Lorenzo M, Martínez PJ, Baldan-Martin M, Ruiz-Hurtado G, Segura J, de la Cuesta F, Barderas MG, Ruilope LM, Vivanco F, Alvarez-Llamas G. Gonzalez-Calero L, et al. Among authors: vivanco f. Transl Res. 2016 Dec;178:25-37.e7. doi: 10.1016/j.trsl.2016.07.003. Epub 2016 Jul 15. Transl Res. 2016. PMID: 27477079
Kalirin and CHD7: novel endothelial dysfunction indicators in circulating extracellular vesicles from hypertensive patients with albuminuria.
de la Cuesta F, Baldan-Martin M, Moreno-Luna R, Alvarez-Llamas G, Gonzalez-Calero L, Mourino-Alvarez L, Sastre-Oliva T, López JA, Vázquez J, Ruiz-Hurtado G, Segura J, Vivanco F, Ruilope LM, Barderas MG. de la Cuesta F, et al. Among authors: vivanco f. Oncotarget. 2017 Feb 28;8(9):15553-15562. doi: 10.18632/oncotarget.14948. Oncotarget. 2017. PMID: 28152519 Free PMC article.
Potential role of new molecular plasma signatures on cardiovascular risk stratification in asymptomatic individuals.
Baldan-Martin M, Lopez JA, Corbacho-Alonso N, Martinez PJ, Rodriguez-Sanchez E, Mourino-Alvarez L, Sastre-Oliva T, Martin-Rojas T, Rincón R, Calvo E, Vazquez J, Vivanco F, Padial LR, Alvarez-Llamas G, Ruiz-Hurtado G, Ruilope LM, Barderas MG. Baldan-Martin M, et al. Among authors: vivanco f. Sci Rep. 2018 Mar 19;8(1):4802. doi: 10.1038/s41598-018-23037-7. Sci Rep. 2018. PMID: 29555916 Free PMC article.
256 results